Article Correctness Is Author's Responsibility: Medical Marketing in the United States, 1997-2016

In this study, Schwartz and Woloshin estimate that spending on marketing of prescription drugs, disease awareness, and health and laboratory services in the US increased from $17.7 to $29.9 billion between 1997 and 2016, with the most rapid increase in direct-to-consumer (DTC) advertising of drugs (mainly high-cost biologics and cancer immunotherapy) and disease awareness campaigns.